No abstract available
MeSH terms
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 1 / economics
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / economics
-
Dose-Response Relationship, Drug
-
Drug Costs
-
Health Care Costs
-
Humans
-
Hypoglycemic Agents / economics
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use
-
Insulin / analogs & derivatives*
-
Insulin / economics
-
Insulin / pharmacology
-
Insulin / therapeutic use*
-
Insulin Detemir
-
Insulin Glargine
-
Insulin, Isophane / economics
-
Insulin, Isophane / pharmacology
-
Insulin, Isophane / therapeutic use*
-
Insulin, Long-Acting
-
United States
-
United States Food and Drug Administration
-
Weight Gain / drug effects
Substances
-
Hypoglycemic Agents
-
Insulin
-
Insulin, Long-Acting
-
Insulin Glargine
-
Insulin Detemir
-
Insulin, Isophane